NATALIE CHAMBERS: Open Payments
NPI 1184905820 · LAVONIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$908 in 68 payments from 16 companies in 2025. Trend: 2023 $925 · 2024 $1,121 · 2025 $908
Food & beverage: $908
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $274 |
| AstraZeneca Pharmaceuticals LP | 7 | $122 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Axsome Therapeutics, Inc. | 5 | $80 |
| Novo Nordisk Inc | 4 | $68 |
| Exact Sciences Corporation | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| PFIZER INC. | 2 | $38 |
| Biogen, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: VRAYLAR, REXULTI, Auvelity, FARXIGA, Cologuard Collection Kit, Wegovy, CAPLYTA, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
